Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-185-2 | CAS number: 1111-78-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 49.8 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 30
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 14.1 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 120
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
According to the REACH Guidance on information requirements and chemical safety assessment, a leading DN(M) EL needs to be derived for every relevant human population and every relevant route, duration and frequency of exposure, if feasible.
Short-term toxicity
Ammonium carbamate is classified as causing serious damage to eyes. As no qualitative data are available on this endoint, a DNEL can not be derived. A qualitative risk assessment will be performed.
The substance is not sensitising, therefore no DNEL has been derived for this endpoint.
Long-term toxicity
No substance-specific data on repeated dose toxicity of ammonium carbamate were available for assessment. Therefore the long-term DNELs for ammonium carbamate have been derived based on the 90-day oral toxicity study with rats with a structural analogue of ammonium carbamate, ammonium chloride. Route-to-route extrapolation was performed in order to derive DNELs for dermal and inhalation routes of exposure. As no quantitative information on absorption of ammonium carbamate was available, the default factors for route-to-route extrapolation suggested by Chapter R.8.4.2 of REACH Guidance on information requirements and chemical safety assessment were used.
Ammonium carbamate is not genotoxic, not carcinogenic and not toxic to reproduction and development, therefore no DNELs have been derived for these endpoints.
DNELs for workers:
Long-term – inhalation, systemic effects (based on the 90 days oral study in rats with a structural analogue ammonium chloride[1])
Description |
Value |
Remark |
Step 1) Relevant dose-descriptor |
NOAEL: 1695.6 mg/kg bw/day |
The exposure of rats to ammonium chloride caused increased incidence of zona glomerulosa hypertrophy (adrenals) and significant body weight reduction in the high-dose animals |
Step 2) Modification of starting point |
2
0.38 m3/kg bw
6.7 m3/10 m3 |
The REACH guidance prescribes a default factor of 2 in case of oral to inhalation extrapolation.
Standard respiratory volume of a rat, corrected for 8 h exposure, as proposed in the REACH Guidance (R.8.4.2)
Correction for activity driven differences of respiratory volumes in workers compared to workers in rest (6.7 m3/10 m3) |
Modified dose-descriptor |
1695.6 x 6.7 / (10 x 0.38 x 2) = 1494.8 mg/m3 |
|
Step 3) Assessment factors |
|
|
Interspecies |
1 |
No factor for allometric scaling is needed in case of inhalation exposure |
Intraspecies
|
5
|
Default assessment factor for workers according to Chapter R.8 of REACH Guidance on information requirements and chemical safety assessment |
Exposure duration |
2 |
Default assessment factor for extrapolation of exposure duration from subchronic to chronic |
Dose response |
1 |
|
Quality of database |
3 |
An additional safety factor of 3 is introduced, as the data are based on the read-across approach |
DNEL |
Value |
|
|
1494.8 / (1 x 5 x 2 x 3 x 1) =49.8 mg/m3 |
Long-term – dermal, systemic effects (based on the 90 days oral study in rats with a structural analogue ammonium chloride)
Description |
Value |
Remark |
Step 1) Relevant dose-descriptor |
NOAEL: 1695.6 mg/kg bw/day |
The exposure of rats to ammonium chloride caused increased incidence of zona glomerulosa hypertrophy (adrenals) and significant body weight reduction in the high-dose animals |
Step 2) Modification of starting point |
1
|
On the assumption that, in general, dermal absorption will not be higher than oral absorption, no default factor should be introduced when performing oral to dermal extrapolation |
Modified dose-descriptor |
1695.6 mg/kg bw/day |
|
Step 3) Assessment factors |
|
|
Interspecies |
4 |
Allometric scaling factor for rat |
Intraspecies
|
5
|
Default assessment factor for workers according to Chapter R.8 of REACH Guidance on information requirements and chemical safety assessment |
Exposure duration |
2 |
Default assessment factor for extrapolation of exposure duration from subchronic to chronic |
Dose response |
1 |
|
Quality of database |
3 |
An additional safety factor of 3 is introduced, as the data are based on the read-across approach |
DNEL |
Value |
|
|
1695.6 / (4 x 5 x 2 x 3 x 1) = 14.1 mg/kg bw/day |
[1] There is also a 90-day inhalation toxicity study available with ammonia with a NOAEC of 262 mg/m3 (24-hour exposure). Using this value as starting point for DNEL derivation results in the following DNEL for long-term exposure by inhalation: 262 x (24/8) x (6.7/10) / (1 x 5 x 2 x 1) = 52.7 mg/m3 for ammonia; assuming that the maximum quantity of NH3possibly released from ammonium carbamate would be 43.6%, this results in a long-term inhalation DNEL of 120.8 mg/m3 for ammonium carbamate.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 12.3 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 60
- Modified dose descriptor starting point:
- NOAEC
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 7.1 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
DNEL related information
- Overall assessment factor (AF):
- 240
- Modified dose descriptor starting point:
- NOAEL
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
Acute/short term exposure
- Hazard assessment conclusion:
- hazard unknown but no further hazard information necessary as no exposure expected
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
According to the REACH Guidance on information requirements and chemical safety assessment, a leading DN(M) EL needs to be derived for every relevant human population and every relevant route, duration and frequency of exposure, if feasible.
Short-term toxicity
Ammonium carbamate is classified for acute oral toxicity (Xn, R22). However, oral uptake is not an anticipated route of exposure in the consumer uses described in the CSR (Use in washing and cleaning products, use in biocide formulations). Furthermore, it is unlikely that potential oral exposure via cross-contamination will lead to exposures exceeding the long-term systemic DNELs. Therefore, no short-term oral DNEL is derived. As the substance is not classified for acute dermal and inhalation toxicity, no short-term DNELs for these routes of exposure need to be derived.
Ammonium carbamate is classified as causing serious damage to eyes. As no qualitative data are available on these endpoints, a DNEL can not be derived. A qualitative risk assessment will be performed.
The substance is not sensitising, therefore no DNEL has been derived for this endpoint.
Long-term toxicity
No substance-specific data on repeated dose toxicity of ammonium carbamate were available for assessment. Therefore the long-term DNELs for ammonium carbamate have been derived based on the 90-day oral toxicity study with rats with a structural analogue of ammonium carbamate, ammonium chloride. Route-to-route extrapolation was performed in order to derive DNELs for dermal and inhalation routes of exposure. As no quantitative information on absorption of ammonium carbamate was available, the default values for route-to route extrapolation suggested by Chapter R.8.4.2 of REACH Guidance on information requirements and chemical safety assessment were used.
Ammonium carbamate is not genotoxic, not carcinogenic and not toxic to reproduction and development, therefore no DNELs have been derived for these endpoints.
DNELs for the general population:
Long-term – inhalation, systemic effects (based on the 90 days oral study in rats with a structural analogue ammonium chloride[1])
Description |
Value |
Remark |
Step 1) Relevant dose-descriptor |
NOAEL: 1695.6 mg/kg bw/day |
The exposure of rats to ammonium chloride caused increased incidence of zona glomerulosa hypertrophy (adrenals) and significant body weight reduction in the high-dose animals |
Step 2) Modification of starting point |
2
1.15m3/kg bw
|
The REACH guidance prescribes a default factor of 2 in case of oral to inhalation extrapolation.
Standard respiratory volume of a rat, corrected for 24 h exposure, as proposed in the REACH Guidance (R.8.4.2) |
Modified dose-descriptor |
1695.6 / (2 x 1.15) = 737.2 mg/m3 |
|
Step 3) Assessment factors |
|
|
Interspecies |
1 |
No factor for allometric scaling is needed in case of inhalation exposure |
Intraspecies
|
10
|
Default assessment factor for general population according to Chapter R.8 of REACH Guidance on information requirements and chemical safety assessment |
Exposure duration |
2 |
Default assessment factor for extrapolation of exposure duration from subchronic to chronic |
Dose response |
1 |
|
Quality of database |
3 |
An additional safety factor of 3 is introduced, as the data are based on the read-across approach |
DNEL |
Value |
|
|
737.2/ (1 x 10 x 2 x 3 x 1) = 12.3 mg/m3 |
Long-term – dermal, systemic effects (based on the 90 days oral study in rats with a structural analogue ammonium chloride)
Description |
Value |
Remark |
Step 1) Relevant dose-descriptor |
NOAEL: 1695.6 mg/kg bw/day |
The exposure of rats to ammonium chloride caused increased incidence of zona glomerulosa hypertrophy (adrenals) and significant body weight reduction in the high-dose animals |
Step 2) Modification of starting point |
1
|
On the assumption that, in general, dermal absorption will not be higher than oral absorption, no default factor should be introduced when performing oral to dermal extrapolation |
Modified dose-descriptor |
1695.6 mg/kg bw/day |
|
Step 3) Assessment factors |
|
|
Interspecies |
4 |
Allometric scaling factor for rat |
Intraspecies
|
10
|
Default assessment factor for general population according to Chapter R.8 of REACH Guidance on information requirements and chemical safety assessment |
Exposure duration |
2 |
Default assessment factor for extrapolation of exposure duration from subchronic to chronic |
Dose response |
1 |
|
Quality of database |
3 |
An additional safety factor of 3 is introduced, as the data are based on the read-across approach |
DNEL |
Value |
|
|
1695.6 / (4 x 10 x 2 x 1 x 3) = 7.1 mg/kg bw/day |
[1] There is also a 90-day inhalation toxicity study available with ammonia with a NOAEC of 262 mg/m3 (24-hour exposure). Using this value as starting point for DNEL derivation results in a comparable DNEL for long-term exposure by inhalation: 262 / (1 x 10 x 2 x 1) = 13.1 mg/m3 for ammonia; assuming that the maximum quantity of NH3 possibly released from ammonium carbamate would be 43.6%, this results in long-term inhalation DNEL of 30 mg/m3 for ammonium carbamate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.